Fusion Antibodies PLC
LSE:FAB
Income Statement
Earnings Waterfall
Fusion Antibodies PLC
Revenue
|
1.6m
GBP
|
Cost of Revenue
|
-1.7m
GBP
|
Gross Profit
|
-117k
GBP
|
Operating Expenses
|
-2.9m
GBP
|
Operating Income
|
-3m
GBP
|
Other Expenses
|
184k
GBP
|
Net Income
|
-2.8m
GBP
|
Income Statement
Fusion Antibodies PLC
Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||
Revenue |
3
N/A
|
2
-28%
|
2
+13%
|
3
+50%
|
4
+19%
|
4
+4%
|
4
+3%
|
5
+13%
|
5
+2%
|
4
-12%
|
3
-31%
|
2
-46%
|
|
Gross Profit | |||||||||||||
Cost of Revenue |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
Gross Profit |
1
N/A
|
1
-47%
|
1
+3%
|
1
+78%
|
2
+24%
|
2
+8%
|
2
+6%
|
2
+16%
|
2
+5%
|
2
-24%
|
1
-69%
|
(0)
N/A
|
|
Operating Income | |||||||||||||
Operating Expenses |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
|
Selling, General & Administrative |
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
Operating Income |
0
N/A
|
(1)
N/A
|
(2)
-4%
|
(1)
+18%
|
(1)
+14%
|
(1)
+5%
|
(1)
-24%
|
(1)
-7%
|
(1)
+1%
|
(2)
-46%
|
(3)
-48%
|
(3)
-6%
|
|
Pre-Tax Income | |||||||||||||
Interest Income Expense |
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
Non-Reccuring Items |
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(1)
N/A
|
(1)
-104%
|
(1)
-4%
|
(1)
+18%
|
(1)
+13%
|
(1)
+5%
|
(1)
-23%
|
(1)
-6%
|
(1)
+1%
|
(2)
-46%
|
(3)
-47%
|
(3)
-6%
|
|
Net Income | |||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(3)
|
(3)
|
(1)
|
(2)
|
(3)
|
(3)
|
|
Net Income (Common) |
(1)
N/A
|
(1)
-82%
|
(1)
+1%
|
(1)
+21%
|
(1)
+30%
|
(1)
+0%
|
(3)
-317%
|
(3)
-4%
|
(1)
+60%
|
(2)
-44%
|
(3)
-50%
|
(3)
-9%
|